Open Access

Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review)

  • Authors:
    • Patrycja Królewska-Daszczyńska
    • Dominika Wendlocha
    • Marta Smycz-Kubańska
    • Sebastian Stępień
    • Aleksandra Mielczarek-Palacz
  • View Affiliations

  • Published online on: November 7, 2022     https://doi.org/10.3892/ol.2022.13585
  • Article Number: 465
  • Copyright: © Królewska-Daszczyńska et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ovarian cancer is a gynecological neoplasm that can be found in women, which, due to diagnostic difficulties, is often detected at advanced stages when treatment becomes a significant problem. Moreover, in a number of cases there is a cancer recurrence and resistance to standard chemotherapy treatment. It has been suggested that cancer stem cells (CSCs) that were not eradicated during therapy may be responsible for this. For this reason, effective therapeutic methods eliminating CSCs are being studied, such as therapy targeting CSCs markers. In addition, numerous studies have also drawn attention to the usefulness of CSCs markers in predicting disease progression and assessing patient's prognosis as well as their importance in the development of treatment resistance. The present review presented research on selected CSCs markers, which may be of significant prognostic and therapeutic importance in ovarian cancer.
View Figures
View References

Related Articles

Journal Cover

December-2022
Volume 24 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Królewska-Daszczyńska P, Wendlocha D, Smycz-Kubańska M, Stępień S and Mielczarek-Palacz A: Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review). Oncol Lett 24: 465, 2022
APA
Królewska-Daszczyńska, P., Wendlocha, D., Smycz-Kubańska, M., Stępień, S., & Mielczarek-Palacz, A. (2022). Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review). Oncology Letters, 24, 465. https://doi.org/10.3892/ol.2022.13585
MLA
Królewska-Daszczyńska, P., Wendlocha, D., Smycz-Kubańska, M., Stępień, S., Mielczarek-Palacz, A."Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review)". Oncology Letters 24.6 (2022): 465.
Chicago
Królewska-Daszczyńska, P., Wendlocha, D., Smycz-Kubańska, M., Stępień, S., Mielczarek-Palacz, A."Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review)". Oncology Letters 24, no. 6 (2022): 465. https://doi.org/10.3892/ol.2022.13585